“We are feeling increasing political pressure in Europe [regarding] the sponsorship of delegates at medical meetings and we are expecting that the system will change dramatically in the future. So we all have to be prepared for the worst.” That was the warning from Anna Frick, conference and exhibition team director, global marketing, AstraZeneca, Mölndal, Sweden; and president, International Pharmaceutical Congress Advisory Association, Basel, Switzerland. (In Europe, unlike the U.S., it's ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Global Pharma Crackdown, you'll also gain access to exclusive premium content.

Already registered? here.